Oscar Siu Hong CHAN ; Rebecca Mei Wan YEUNG ; Anne Wing Mui LEE
Chinese Medical Journal 2013;126(12):2390-2398
Antineoplastic Agents ; administration & dosage ; Carcinoma, Non-Small-Cell Lung ; drug therapy ; Cost-Benefit Analysis ; Humans ; Lung Neoplasms ; drug therapy ; Meta-Analysis as Topic